Perri M
J Pharm Mark Manage. 1989;3(4):21-36. doi: 10.3109/j058v03n04_03.
This experiment tested the effect of an informational radio advertising intervention on consumer attitudes toward generic medications, consumer attitudes toward the advertising of generic medicines, and the potential for consumers to request generic substitutes for their prescriptions in the future. The informational themes of the advertising intervention included price, quality, product availability, safety, and the role of the pharmacist in drug product selection. Results indicated 28% of the 205 radio station listeners surveyed were able to recall the generic ads. The attitudes of respondents indicating recall of the advertisements were no different from those of respondents unable to recall the advertisements. Consumer attitudes toward generics and the advertising of generic medicines were favorable. Most consumers (73%) thought that subjects such as generic medications should be advertised more often. Many consumers (50%) indicated they would like to hear more ads about generic medications. Patients believed the ads provided information they have a right to know (83%) and information that would be useful to them (77%). Consumers thought generic drugs were just as safe (67%) and effective (62%) as brand name medications. Consumers who recalled the ads were significantly (p less than .05) more likely to indicate they would ask their pharmacists about generic medications on their next prescriptions. This implies that the informational advertising intervention may have been effective in stimulating patient requests for generics in the future.
本实验测试了信息性广播广告干预对消费者对非专利药品的态度、消费者对非专利药品广告的态度以及消费者未来要求用非专利替代品替代其处方药的可能性的影响。广告干预的信息主题包括价格、质量、产品可得性、安全性以及药剂师在药品选择中的作用。结果显示,在接受调查的205名广播电台听众中,28%的人能够回忆起非专利药品广告。表示回忆起广告的受访者的态度与无法回忆起广告的受访者的态度没有差异。消费者对非专利药品及其广告持积极态度。大多数消费者(73%)认为非专利药品等主题应该更频繁地进行广告宣传。许多消费者(50%)表示他们希望听到更多关于非专利药品的广告。患者认为这些广告提供了他们有权了解的信息(83%)以及对他们有用的信息(77%)。消费者认为非专利药品与品牌药一样安全(67%)和有效(62%)。回忆起广告的消费者更有可能(p小于0.05)表示他们会在下一次开处方时向药剂师询问非专利药品。这意味着信息性广告干预可能有效地刺激了患者未来对非专利药品的需求。